Eye rosacea study tests if Low-Dose antibiotics cause less resistance
NCT ID NCT05296837
First seen Mar 11, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study looks at how two different doses of the antibiotic doxycycline affect the development of antibiotic resistance in people with ocular rosacea, a chronic eye condition. Researchers will compare a standard dose (100 mg) to a lower, anti-inflammatory dose (40 mg or less) to see which leads to fewer resistance genes in the body. The goal is to understand if the lower dose is safer for long-term use without promoting resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL RESISTANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Farncisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.